Serum IL-6: A Biomarker in Childhood Asthma?
暂无分享，去创建一个
W. Busse | G. O'Connor | L. Bacharier | J. Gern | R. Wood | Andrew H. Liu | M. Gill | G. K. Khurana Hershey | D. Jackson | R. Gruchalla | J. Pongracic | A. Calatroni | M. Kattan | C. Kercsmar | L. Wheatley | Haejin Kim | Jack W. Hu | A. Liu | Shilpa J Patel | Shilpa Patel
[1] P. Howarth,et al. Epithelial IL‐6 trans‐signaling defines a new asthma phenotype with increased airway inflammation , 2019, The Journal of allergy and clinical immunology.
[2] H. Ortega,et al. Asthma Exacerbations Associated with Lung Function Decline in Patients with Severe Eosinophilic Asthma. , 2018, The journal of allergy and clinical immunology. In practice.
[3] P. Gergen,et al. Asthma phenotypes in inner-city children. , 2016, The Journal of allergy and clinical immunology.
[4] P. Gergen,et al. Distinguishing characteristics of difficult-to-control asthma in inner-city children and adolescents. , 2016, The Journal of allergy and clinical immunology.
[5] E. Bleecker,et al. Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts. , 2016, The Lancet. Respiratory medicine.
[6] P. Gergen,et al. Development and validation of the Composite Asthma Severity Index--an outcome measure for use in children and adolescents. , 2012, The Journal of allergy and clinical immunology.
[7] William W Busse,et al. Severe exacerbations and decline in lung function in asthma. , 2009, American journal of respiratory and critical care medicine.